A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
Clinical trial NCT05621668 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05621668
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2027-09-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.